6th Annual Gene Therapy for Rare Disorders Europe
Evvnt Promotion / evvnt
Archivo
25.10.2022 - 27.10.2022 London Marriott Hotel Regents Park, 128 King Henry's Road, NW3 3ST London, United Kingdom
Time: 8:00 am to 5:00 pm
Temas de la conferencia
As more and more companies gear up for clinical activity and near approval decisions, the need to have an in-depth understanding of the regulatory frameworks and how these feed into clinical development and manufacturing processes is as vital as ever.
As more and more companies gear up for clinical activity and near approval decisions, the need to have an in-depth understanding of the regulatory frameworks and how these feed into clinical development and manufacturing processes is as vital as ever.
La Sociedad Científica
Hanson Wade
Hanson Wade
Observaciones
Speakers: Eva Andres-Mateos, Senior Director of Translational Research, Atsena Therapeutics, Inês Alves, Patient Expert and Member of the Committee for Orphan Medicinal Products, EMA, Stuart Beattie, Gene Therapy Global Regulatory CMC, Biogen
Speakers: Eva Andres-Mateos, Senior Director of Translational Research, Atsena Therapeutics, Inês Alves, Patient Expert and Member of the Committee for Orphan Medicinal Products, EMA, Stuart Beattie, Gene Therapy Global Regulatory CMC, Biogen
Información e inscripción:
https://go.evvnt.com/1234024-2?pid=4832
Ms. Emily Birt
Investigación clínica, Salud Pública
Idioma
Inglés
Inglés
Cuota del Congreso
GBP 2099.00 - GBP 4496.00
GBP 2099.00 - GBP 4496.00
Los participantes esperaban
1000
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
